TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Naveen S Vasudev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.